微信公众号:蹊之美股生物医药 / CaesarBiotech
标的公司:KemPharm, Inc. (NASDAQ:KMPH)
KemPharm,Inc. (KMPH) 宣布因获得美国食品和药物管理局(FDA)对AZSTARYS™ 的批准,收到一笔1000万美元的监管里程碑付款(regulatory milestone payment)。此项付款根据与Gu...查看全文
KemPharm(KMPH)2021-04-09 04:48
$KemPharm(KMPH)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001437749-21-008560 Act: 34 Size: 1 MB 网页链接查看全文
KemPharm(KMPH)2021-04-09 04:42
$KemPharm(KMPH)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-21-008575 Act: 33 Size: 629 KB 网页链接查看全文
KemPharm(KMPH)2021-03-12 05:42
$KemPharm(KMPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-005708 Act: 34 Size: 2 MB 网页链接查看全文
KemPharm(KMPH)2021-03-12 19:06
$KemPharm(KMPH)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001437749-21-005788 Act: 33 Size: 2 MB 网页链接查看全文
KemPharm(KMPH)2021-03-12 19:12
$KemPharm(KMPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-21-005785 Act: 34 Size: 11 MB 网页链接查看全文
黄野仁2023-01-23 21:11
$KemPharm(KMPH)$
kempharm上週兩個消息:T博士離開管理層,重新回到科研前線。以他的業餘管理水平,被視作好消息
其次是Az藥上週腳本超過5400,上市以來新高,開始銷路有點起色查看全文
黄野仁2022-10-24 13:28
$KemPharm(KMPH)$
看看对手AYTU旗下两只多动症药物最新脚本/周:
AYTU Adzenys,week ending/scripts
10/14------------4.880
AYTU Cotempla,week ending/scripts
10/14------------2,740
他的季报是这两个利润:ADHD (Adzenys XR-ODT and Cotempla XR-ODT) net revenue...查看全文
黄野仁2022-05-16 10:16
$KemPharm(KMPH)$ $Orphazyme(ORPH)$
T博士對自己這麽自信?Azstarys銷售還沒上軌道又1700萬買個丹麦生物技术公司 Orphazyme ApS的Arimoclomol?
一直以爲kmph會給別人壓價收購,想不到是他趁生科低潮收購別人。
不過看歷史,T博士這家夥對FDA批准很有心得,他的Apadaz,Azstarys都順利...查看全文
$KemPharm(KMPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-23-004793 Act: 34 Size: 77 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001437749-23-004784 Act: 34 Size: 211 KB 网页链接
$KemPharm(KMPH)$ PREC14A Preliminary proxy statements, contested solicitations Accession Number: 0001437749-23-004742 Act: 34 Size: 868 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001437749-23-004450 Act: 34 Size: 350 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-23-001701 Act: 34 Size: 237 KB 网页链接
$KemPharm(KMPH)$ 8-K Current report, item 8.01 Accession Number: 0001437749-23-001447 Act: 34 Size: 166 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001059 Size: 4 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-001060 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000919 Size: 5 KB 网页链接
$KemPharm(KMPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-23-000915 Size: 5 KB 网页链接